Results 81 to 90 of about 1,473 (145)

Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health. [PDF]

J Intern Med
Maioli S, Nalvarte I, Ankarcrona M, Schultzberg M, Zuloaga KL, Goikolea J, Visser PJ, De Strooper B, Winblad B, Pizzo P, Williams PA, Rodriguez-Rodriguez P, Naia L.   +12 more
europepmc   +1 more source

From cholesterol to glucose: uncovering how statins induce β-cell dysfunction to promote type 2 diabetes. [PDF]

J Endocrinol
Barrow BM, Wander PL, Zraika S.
europepmc   +1 more source

The Role of Lipid Alteration in Multiple Sclerosis. [PDF]

Int J Mol Sci
Damiza-Detmer A, Pawełczyk M, Głąbiński A.   +2 more
europepmc   +1 more source

Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation. [PDF]

J Xenobiot
Durairaj P, Liu ZL.
europepmc   +1 more source

From Sunlight to Signaling: Evolutionary Integration of Vitamin D and Sterol Metabolism. [PDF]

Metabolites
Raczyk M, Carlberg C.
europepmc   +1 more source

The multifaceted roles of the transcription factor <i>SP1</i> in the pathogenesis of Alzheimer's disease: From molecular regulation to therapeutic targets. [PDF]

Alzheimers Dement (N Y)
Lv Z, Liu X, Huang Q, Liu H, Xu Z, Xu P.
europepmc   +1 more source

Bile Acid Profile Differs Between Brain Regions in Rodents and Is Disrupted in a Rodent Model of Alzheimer's Disease. [PDF]

Compr Physiol
Reuter MA, Moreno R, Agabao-Tucker ME, Shishani R, Bustamante JM, Marfori Z, Richieri T, Valenzuela AE, Taha AY, Lein PJ, Nandakumar R, Cummings BP.   +11 more
europepmc   +1 more source

Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer's Disease Therapeutics. [PDF]

ACS Pharmacol Transl Sci
Boyarko B, Podvin S, Greenberg B, Arnold S, Juanes AM, van der Kant R, Goldstein L, Momper JD, Bang A, Silverman J, Feldman HH, Hook V.   +11 more
europepmc   +1 more source